HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sylvia Hartmann Selected Research
Sylvia Hartmann Research Topics
Disease
23
Neoplasms (Cancer)
04/2024 - 09/2008
18
Hodgkin Disease (Hodgkin's Disease)
01/2023 - 09/2008
11
Lymphoma (Lymphomas)
02/2024 - 05/2009
6
Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2023 - 08/2017
6
B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 05/2009
5
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2023 - 01/2018
4
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 08/2017
3
Cholangiocarcinoma
05/2018 - 02/2017
2
Lymphadenitis (Adenitis)
10/2023 - 10/2019
2
Inflammation (Inflammations)
11/2021 - 10/2018
2
T-Cell Lymphoma (Lymphoma, T Cell)
01/2019 - 09/2008
2
Sarcoma (Soft Tissue Sarcoma)
01/2017 - 01/2016
2
Hepatocellular Carcinoma (Hepatoma)
01/2015 - 12/2014
2
Carcinoma (Carcinomatosis)
10/2013 - 05/2011
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2024
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
04/2024
1
Hypersensitivity (Allergy)
10/2023
1
Burkitt Lymphoma (Burkitt's Lymphoma)
08/2022
1
Mucormycosis
03/2022
1
Invasive Fungal Infections
03/2022
1
Breast Neoplasms (Breast Cancer)
12/2020
1
Mycoses (Diseases, Fungus)
11/2020
1
Histoplasmosis
11/2020
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020
1
Paraproteinemias (Monoclonal Gammopathy)
01/2020
1
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
03/2018
1
Rhabdomyoma
03/2017
1
Sclerosing Cholangitis
02/2017
1
Cholangitis
02/2017
1
Myopericytoma
01/2016
1
Castleman Disease (Castleman's Disease)
01/2016
1
Hepatitis C
12/2014
1
Cerebellar Diseases (Cerebellar Syndrome)
10/2013
1
Sclerosis
10/2013
Drug/Important Bio-Agent (IBA)
8
Proteins (Proteins, Gene)
FDA Link
10/2021 - 05/2012
6
MicroRNAs (MicroRNA)
IBA
01/2023 - 12/2014
5
Antigens
IBA
02/2023 - 01/2019
5
Autoantigens
IBA
08/2022 - 12/2018
4
DNA (Deoxyribonucleic Acid)
IBA
11/2020 - 09/2008
3
RNA (Ribonucleic Acid)
IBA
11/2021 - 12/2020
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
04/2024 - 06/2023
2
Immune Checkpoint Inhibitors
IBA
11/2023 - 02/2023
2
Rituximab (Mabthera)
FDA Link
10/2023 - 01/2020
2
Biomarkers (Surrogate Marker)
IBA
10/2023 - 12/2014
2
Protein Isoforms (Isoforms)
IBA
08/2022 - 03/2017
2
Autoantibodies
IBA
08/2022 - 10/2021
2
Transcription Factors (Transcription Factor)
IBA
06/2021 - 03/2018
2
Formaldehyde (Formol)
FDA Link
11/2020 - 08/2017
2
Paraffin
IBA
11/2020 - 08/2017
2
Monoclonal Antibodies
IBA
01/2020 - 03/2017
2
neurabin
IBA
01/2020 - 12/2018
2
Ligands
IBA
09/2017 - 01/2017
2
Messenger RNA (mRNA)
IBA
01/2017 - 05/2011
2
Cyclin D1
IBA
05/2016 - 02/2014
2
Carrier Proteins (Binding Protein)
IBA
12/2013 - 05/2011
1
Phosphotransferases (Kinase)
IBA
04/2024
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
04/2024
1
Immunoglobulin M (IgM)
IBA
02/2024
1
Bendamustine Hydrochloride
FDA Link
10/2023
1
Catecholamines
IBA
10/2023
1
Therapeutic Uses
IBA
02/2023
1
Ribosomal RNA
IBA
03/2022
1
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
10/2021
1
LDL-Receptor Related Protein-Associated Protein
IBA
10/2021
1
LDL Lipoproteins (beta Lipoproteins)
IBA
10/2021
1
Collagen
IBA
12/2020
1
Saposins
IBA
01/2020
1
Brentuximab Vedotin
IBA
10/2019
1
Suspensions
IBA
10/2019
1
CCR4 Receptors
IBA
01/2019
1
Growth Factor Receptors
IBA
01/2019
1
Epitopes
IBA
12/2018
1
Exotoxins
IBA
12/2018
1
Chimeric Antigen Receptors
IBA
11/2018
1
Chemokines
IBA
10/2018
1
Cytokines
IBA
10/2018
1
Antigen-Antibody Complex (Immune Complex)
IBA
12/2017
1
Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)
IBA
08/2017
1
carboxyl radical (COO-)
IBA
08/2017
1
serglycin
IBA
03/2017
1
Actins (F Actin)
IBA
03/2017
1
Antibodies
IBA
03/2017
1
Immunoglobulin G (IgG)
IBA
02/2017
1
Programmed Cell Death 1 Receptor
IBA
01/2017
1
Interferons
IBA
01/2017
1
CXC Chemokines
IBA
01/2017
1
Thioredoxins
IBA
01/2017
1
Chromatin
IBA
01/2017
1
Beclin-1
IBA
07/2016
1
Lactic Acid (Lactate)
FDA Link
Generic
05/2016
1
Sorafenib (BAY 43-9006)
FDA Link
01/2015
1
Capsules (Microcapsules)
IBA
12/2014
1
Metals
IBA
12/2013
Therapy/Procedure
5
Therapeutics
03/2022 - 07/2016
2
Lasers (Laser)
10/2023 - 12/2014
2
Drug Therapy (Chemotherapy)
07/2023 - 01/2021
1
Cell Transplantation
03/2018
1
Time-to-Treatment
01/2018
1
Liver Transplantation
02/2017
1
Tonsillectomy
10/2013